• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Device Problem Product Quality Problem (1506)
Patient Problem No Code Available (3191)
Event Date 01/10/2020
Event Type  Injury  
Manufacturer Narrative
The date the article was accepted by the journal was used as the event date, since no date of publication is known as of today.The patient age and patient gender reflect the mean age and gender stated in the article.(b)(4).
 
Event Description
The following publication was reviewed: ¿twenty-two year multicentre experience of late open conversions after endovascular abdominal aneurysm repair¿ (paolo perini et.Al, eur j vasc endovasc surg, accepted january 10, 2020).In the article ten vascular centers reviewed all patients requiring late open conversions (locs) after endovascular abdominal aneurysm repair (evar) from 1996 to 2017.Loc is defined as more or equal to 30 days after initial evar, undergoing total or partial endograft explantation.The article included a total of 232 patients and stated that 42 of them (18.1%) were initially treated with gore® excluder® aaa endoprostheses.It was stated that the main reason for loc was the presence of an endoleak in 80.2% (186/232) cases.Among these, 13 patients presented with endotension.The physician stated that the reported adverse events are related to disease progression.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
joerg kersten
1500 n. 4th street
9285263030
MDR Report Key9914722
MDR Text Key188892596
Report Number3007284313-2020-00089
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 03/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-